According to The Cancer Genome Atlas (TCGA) database, GBM is characterized by aberrant amplification or mutation of EGFR, PDGFRA, CDK4, NF1, HER2, TP53, PIK3R1 and TERT.6, 7. The gene discussed is EGFR; the disease is glioblastoma.